SE9503672L - Partiklar för fördröjd frisättning - Google Patents

Partiklar för fördröjd frisättning

Info

Publication number
SE9503672L
SE9503672L SE9503672A SE9503672A SE9503672L SE 9503672 L SE9503672 L SE 9503672L SE 9503672 A SE9503672 A SE 9503672A SE 9503672 A SE9503672 A SE 9503672A SE 9503672 L SE9503672 L SE 9503672L
Authority
SE
Sweden
Prior art keywords
core particles
particles
organic solvent
active substance
delayed release
Prior art date
Application number
SE9503672A
Other languages
Unknown language ( )
English (en)
Other versions
SE9503672D0 (sv
SE505146C2 (sv
Inventor
Nils-Ove Gustafsson
Timo Laakso
Peter Fyhr
Monica Joensson
Original Assignee
Biogram Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogram Ab filed Critical Biogram Ab
Priority to SE9503672A priority Critical patent/SE505146C2/sv
Publication of SE9503672D0 publication Critical patent/SE9503672D0/sv
Priority to DE69636177T priority patent/DE69636177T2/de
Priority to ES96935641T priority patent/ES2125209T3/es
Priority to JP9515728A priority patent/JP2000501380A/ja
Priority to ES01117830T priority patent/ES2267637T3/es
Priority to PCT/SE1996/001091 priority patent/WO1997014408A1/en
Priority to DE69625240T priority patent/DE69625240T2/de
Priority to EP96935641A priority patent/EP0869774B1/en
Priority to EP06010350A priority patent/EP1716849A1/en
Priority to KR1019980702757A priority patent/KR100482262B1/ko
Priority to IL12405296A priority patent/IL124052A/xx
Priority to HU9901205A priority patent/HUP9901205A3/hu
Priority to AT01117830T priority patent/ATE326953T1/de
Priority to DE0869774T priority patent/DE869774T1/de
Priority to US09/051,709 priority patent/US6120787A/en
Priority to PT96935641T priority patent/PT869774E/pt
Priority to CZ19981173A priority patent/CZ293059B6/cs
Priority to DK96935641T priority patent/DK0869774T3/da
Priority to CA 2234615 priority patent/CA2234615C/en
Priority to AT96935641T priority patent/ATE228826T1/de
Priority to AU73478/96A priority patent/AU699080B2/en
Priority to EP01117830A priority patent/EP1142569B1/en
Publication of SE9503672L publication Critical patent/SE9503672L/sv
Publication of SE505146C2 publication Critical patent/SE505146C2/sv
Priority to NO19981558A priority patent/NO320392B1/no
Priority to HK98112027A priority patent/HK1011182A1/xx
Priority to HK01108604A priority patent/HK1038309A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
SE9503672A 1995-10-19 1995-10-19 Partiklar för fördröjd frisättning SE505146C2 (sv)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE9503672A SE505146C2 (sv) 1995-10-19 1995-10-19 Partiklar för fördröjd frisättning
EP01117830A EP1142569B1 (en) 1995-10-19 1996-09-03 Coating of small particles
AT01117830T ATE326953T1 (de) 1995-10-19 1996-09-03 Umhüllung kleiner partikel
US09/051,709 US6120787A (en) 1995-10-19 1996-09-03 Sustained release particles
JP9515728A JP2000501380A (ja) 1995-10-19 1996-09-03 持続放出性粒子
ES01117830T ES2267637T3 (es) 1995-10-19 1996-09-03 Revestimiento de pequeñas particulas.
PCT/SE1996/001091 WO1997014408A1 (en) 1995-10-19 1996-09-03 Sustained release particles
DE69625240T DE69625240T2 (de) 1995-10-19 1996-09-03 Methode zur herstellung von partikeln mit verzoegerter freisetzung
EP96935641A EP0869774B1 (en) 1995-10-19 1996-09-03 Method for manufacturing sustained release particles
EP06010350A EP1716849A1 (en) 1995-10-19 1996-09-03 Coating of small particles
KR1019980702757A KR100482262B1 (ko) 1995-10-19 1996-09-03 서방성입자
IL12405296A IL124052A (en) 1995-10-19 1996-09-03 Method of preparing parenterally administrable sustained release microparticles and microparticles obtainable thereby
HU9901205A HUP9901205A3 (en) 1995-10-19 1996-09-03 Sustained release particles
DE69636177T DE69636177T2 (de) 1995-10-19 1996-09-03 Umhüllung kleiner Partikel
DE0869774T DE869774T1 (de) 1995-10-19 1996-09-03 Partikel mit verzögerter freisetzung
ES96935641T ES2125209T3 (es) 1995-10-19 1996-09-03 Metodo para fabricar particulas de liberacion sostenida.
PT96935641T PT869774E (pt) 1995-10-19 1996-09-03 Metodo para a producao de particulas de libertacao retardada
CZ19981173A CZ293059B6 (cs) 1995-10-19 1996-09-03 Způsob přípravy mikročástic s trvalým uvolňováním
DK96935641T DK0869774T3 (da) 1995-10-19 1996-09-03 Fremgangsmåde til fremstilling af vedvarende frigivende partikler
CA 2234615 CA2234615C (en) 1995-10-19 1996-09-03 Sustained release particles
AT96935641T ATE228826T1 (de) 1995-10-19 1996-09-03 Methode zur herstellung von partikeln mit verzoegerter freisetzung
AU73478/96A AU699080B2 (en) 1995-10-19 1996-09-03 Sustained release particles
NO19981558A NO320392B1 (no) 1995-10-19 1998-04-06 Fremgangsmate for fremstilling av parenteralt administrerbare mikrokapsler med vedvarende frigivelse, og mikropartikler ifolge denne fremgangsmaten
HK98112027A HK1011182A1 (en) 1995-10-19 1998-11-16 Method for manufacturing sustained release particles
HK01108604A HK1038309A1 (en) 1995-10-19 1998-11-16 Coating of small particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503672A SE505146C2 (sv) 1995-10-19 1995-10-19 Partiklar för fördröjd frisättning

Publications (3)

Publication Number Publication Date
SE9503672D0 SE9503672D0 (sv) 1995-10-19
SE9503672L true SE9503672L (sv) 1997-04-20
SE505146C2 SE505146C2 (sv) 1997-06-30

Family

ID=20399887

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9503672A SE505146C2 (sv) 1995-10-19 1995-10-19 Partiklar för fördröjd frisättning

Country Status (17)

Country Link
US (1) US6120787A (sv)
EP (3) EP1716849A1 (sv)
JP (1) JP2000501380A (sv)
KR (1) KR100482262B1 (sv)
AT (2) ATE228826T1 (sv)
AU (1) AU699080B2 (sv)
CZ (1) CZ293059B6 (sv)
DE (3) DE869774T1 (sv)
DK (1) DK0869774T3 (sv)
ES (2) ES2267637T3 (sv)
HK (1) HK1011182A1 (sv)
HU (1) HUP9901205A3 (sv)
IL (1) IL124052A (sv)
NO (1) NO320392B1 (sv)
PT (1) PT869774E (sv)
SE (1) SE505146C2 (sv)
WO (1) WO1997014408A1 (sv)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2304096C (en) * 1997-09-18 2003-09-09 Skyepharma Inc. Sustained-release liposomal anesthetic compositions
US20070212422A1 (en) * 1999-11-10 2007-09-13 Manfred Keller Dry powder for inhalation
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
ES2169980B1 (es) 1999-12-17 2003-11-01 Lipotec Sa Microcapsulas para la liberacion prolongada de farmacos.
IT1318380B1 (it) * 2000-03-09 2003-08-25 Intercos Italiana Polvere cosmetica rivestita.
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
DE60039540D1 (de) * 2000-05-26 2008-08-28 Frohwitter Bernhard Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
SE517422C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
EP1328258B1 (en) * 2000-10-06 2008-10-01 Pacira Pharmaceuticals Inc A controlled-release, parenterally administrable microparticle preparation
ATE430558T1 (de) 2000-10-27 2009-05-15 Baxter Healthcare Sa Herstellung von mikrokügelchen
SE518007C2 (sv) 2000-11-16 2002-08-13 Bioglan Ab Förfarande för framställning av mikropartiklar
US7034037B2 (en) * 2001-06-29 2006-04-25 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
US7030127B2 (en) * 2001-06-29 2006-04-18 Ethicon, Inc. Composition and medical devices utilizing bioabsorbable polymeric waxes
US6967234B2 (en) * 2002-12-18 2005-11-22 Ethicon, Inc. Alkyd-lactone copolymers for medical applications
ES2307779T3 (es) * 2001-08-16 2008-12-01 Baxter International Inc. Formulaciones de microparticulas a base de propelentes.
US7105181B2 (en) 2001-10-05 2006-09-12 Jagotec, Ag Microparticles
AU2003216288B2 (en) 2002-02-13 2009-09-24 Duke University Modulation of immune response by non-peptide binding stress response polypeptides
SE0201599D0 (sv) 2002-03-21 2002-05-30 Skyepharma Ab Microparticles
US7005136B2 (en) 2002-03-29 2006-02-28 Ethicon, Inc. Bone replacement materials utilizing bioabsorbable liquid polymers
US7326426B2 (en) * 2002-03-29 2008-02-05 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable liquid polymers
US7368125B2 (en) * 2002-06-05 2008-05-06 Ethicon, Inc. Amphiphilic polymers for medical applications
US7026374B2 (en) * 2002-06-25 2006-04-11 Aruna Nathan Injectable microdispersions for medical applications
US7101566B2 (en) * 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
WO2004030631A2 (en) 2002-10-01 2004-04-15 Chiron Corporation Anti-cancer and anti-infectious disease compositions and methods for using same
US6872799B2 (en) 2002-12-18 2005-03-29 Ethicon, Inc. Functionalized polymers for medical applications
US6866860B2 (en) 2002-12-19 2005-03-15 Ethicon, Inc. Cationic alkyd polyesters for medical applications
US20040120981A1 (en) * 2002-12-20 2004-06-24 Aruna Nathan Crosslinked alkyd polyesters for medical applications
JP2006523613A (ja) * 2002-12-20 2006-10-19 エスティ．ジェイムス アソシエイト エルエルシー／フェイバー リサーチ シリーズ 徐放性医薬投与のための被覆粒子
US7060299B2 (en) * 2002-12-31 2006-06-13 Battelle Memorial Institute Biodegradable microparticles that stabilize and control the release of proteins
JP2009513493A (ja) * 2003-06-26 2009-04-02 メディオラニューム ファーマシューティカルス リミテッド 制限された活性成分の初期放出を有し、続いてその徐放性を直線的に変化させる皮下インプラント
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
WO2005035088A2 (en) * 2003-07-18 2005-04-21 Baxter International, Inc. Method for preparing small spherical by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
CA2532874A1 (en) * 2003-07-22 2005-02-03 Baxter International Inc. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
KR100453273B1 (ko) * 2003-09-04 2004-10-15 주식회사 펩트론 초음파 이중공급노즐을 이용한 서방성 미립구의 제조 방법
US7456254B2 (en) * 2004-04-15 2008-11-25 Alkermes, Inc. Polymer-based sustained release device
US20060110423A1 (en) * 2004-04-15 2006-05-25 Wright Steven G Polymer-based sustained release device
US8617613B2 (en) 2004-04-15 2013-12-31 Alkermes Pharma Ireland Limited Polymer-based sustained release device
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
WO2005112885A2 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
ATE409025T1 (de) 2004-05-12 2008-10-15 Baxter Int Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
US8333995B2 (en) 2004-05-12 2012-12-18 Baxter International, Inc. Protein microspheres having injectable properties at high concentrations
EP1824460B1 (en) * 2004-11-10 2014-12-24 Tolmar Therapeutics, Inc. A stabilized polymeric delivery system
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8318210B2 (en) 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
US20060260777A1 (en) * 2005-04-27 2006-11-23 Julia Rashba-Step Surface-modified microparticles and methods of forming and using the same
US8017152B2 (en) * 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP1726299A3 (en) 2005-05-27 2007-04-18 StratoSphere Pharma AB Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP1931387A4 (en) * 2005-09-07 2012-07-11 Southwest Res Inst BIODEGRADABLE MICROTEILED PHARMACEUTICAL FORMULATIONS WITH IMPROVED RELEASE RATES
US9693967B2 (en) 2005-09-07 2017-07-04 Southwest Research Institute Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates
US20070092553A1 (en) * 2005-10-21 2007-04-26 Pfab Lp Compositions and methods of making rapidly dissolving lonically masked formulations
US20080286375A1 (en) * 2005-11-15 2008-11-20 Amorepacific Corporation Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
GB0602897D0 (en) * 2006-02-13 2006-03-22 Jagotec Ag Improvements In Or Relating To Dry Powder Inhaler Devices
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
JP5118139B2 (ja) 2006-08-04 2013-01-16 バクスター・インターナショナル・インコーポレイテッド 新規発症自己免疫性糖尿病を予防および／または逆転させるためのマイクロスフィアに基づく組成物
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
MX2009003661A (es) * 2006-10-06 2009-04-22 Baxter Int Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas.
GB0622818D0 (en) * 2006-11-15 2006-12-27 Jagotec Ag Improvements in or relating to organic compounds
GB0625303D0 (en) * 2006-12-19 2007-01-24 Jagotec Ag Improvements in and relating to metered dose inhalers
AU2008231093A1 (en) * 2007-03-22 2008-10-02 Alkermes, Inc. Coacervation process
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
JP2010529040A (ja) * 2007-05-30 2010-08-26 ネオス・セラピューティクス・エルピー イオン性樹脂系の懸濁液における薬物放出の調節
US20080317865A1 (en) * 2007-06-20 2008-12-25 Alkermes, Inc. Quench liquids and washing systems for production of microparticles
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US8323615B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8367427B2 (en) 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
KR101331136B1 (ko) 2011-01-12 2013-11-26 아주대학교산학협력단 약물의 초기 과다 방출 제어를 위한 약물전달 제형 및 이의 제조방법
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
BR112015024234B1 (pt) 2013-03-21 2022-11-16 Eupraxia Pharmaceuticals USA LLC Composição farmacêutica de liberação sustentada injetável, uso da mesma para diminuir inflamação ou controlar dor e método para formar micropartículas revestidas
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
TR201808237T4 (tr) 2015-10-27 2018-07-23 Eupraxia Pharmaceuticals Inc Lokal anestetiklerin sürekli salım formülasyonları.
TWI814219B (zh) 2016-05-16 2023-09-01 美商因塔希亞治療公司 升糖素受體選擇性多肽和彼之使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
KR102383448B1 (ko) * 2020-04-20 2022-04-06 한국화학연구원 락트산 또는 글리콜산을 포함하는 미립구형 서방출 제제 및 그의 제조방법

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117027A (en) * 1960-01-08 1964-01-07 Wisconsin Alumni Res Found Apparatus for coating particles in a fluidized bed
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
US4637905A (en) * 1982-03-04 1987-01-20 Batelle Development Corporation Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones
CH661206A5 (fr) * 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
CA1236641A (en) * 1984-07-06 1988-05-10 Motoaki Tanaka Copolymer of lactic acid and glycolic acid and method for producing same
JP2551756B2 (ja) * 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
SE459005B (sv) * 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
CA1309022C (en) * 1986-04-07 1992-10-20 Richard James Harwood Method for the preparation of a sustained release pharmaceutical composition and the composition prepared thereby
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
US5275819A (en) * 1989-02-06 1994-01-04 Amer Particle Technologies Inc. Drug loaded pollen grains with an outer coating for pulsed delivery
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
EP0550436A1 (en) * 1989-11-06 1993-07-14 Alkermes Controlled Therapeutics, Inc. Protein microspheres and methods of using them
FR2663207B1 (fr) * 1990-06-15 1993-04-30 Rhone Poulenc Nutrition Animal Procede d'enrobage par un polymere ph sensible de principes actifs.
EP0576675A4 (en) * 1991-03-25 1994-06-01 Fujisawa Pharmaceutical Co Long-acting pharmaceutical preparation
DE69220317T2 (de) * 1991-10-01 1997-10-16 Takeda Chemical Industries Ltd Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
US5288502A (en) * 1991-10-16 1994-02-22 The University Of Texas System Preparation and uses of multi-phase microspheres
PT674506E (pt) * 1992-12-02 2001-01-31 Alkermes Inc Microsferas contendo hormona de crescimento com libertacao controlada
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres

Also Published As

Publication number Publication date
DE69625240D1 (de) 2003-01-16
DK0869774T3 (da) 2003-03-24
EP0869774A1 (en) 1998-10-14
KR19990064267A (ko) 1999-07-26
CZ293059B6 (cs) 2004-01-14
ES2267637T3 (es) 2007-03-16
DE869774T1 (de) 1999-06-02
CZ117398A3 (cs) 1998-09-16
DE69636177T2 (de) 2007-03-29
HK1011182A1 (en) 1999-07-09
NO981558L (no) 1998-04-06
ATE228826T1 (de) 2002-12-15
EP1716849A1 (en) 2006-11-02
IL124052A (en) 2000-11-21
HUP9901205A3 (en) 2001-04-28
ATE326953T1 (de) 2006-06-15
NO981558D0 (no) 1998-04-06
US6120787A (en) 2000-09-19
DE69625240T2 (de) 2003-09-11
EP1142569A2 (en) 2001-10-10
EP1142569B1 (en) 2006-05-24
SE9503672D0 (sv) 1995-10-19
AU7347896A (en) 1997-05-07
JP2000501380A (ja) 2000-02-08
SE505146C2 (sv) 1997-06-30
HUP9901205A2 (hu) 1999-08-30
EP1142569A3 (en) 2003-05-21
KR100482262B1 (ko) 2006-04-14
DE69636177D1 (de) 2006-06-29
ES2125209T3 (es) 2003-07-01
AU699080B2 (en) 1998-11-19
EP0869774B1 (en) 2002-12-04
WO1997014408A1 (en) 1997-04-24
PT869774E (pt) 2003-04-30
ES2125209T1 (es) 1999-03-01
NO320392B1 (no) 2005-11-28

Similar Documents

Publication Publication Date Title
SE9503672L (sv) Partiklar för fördröjd frisättning
HRP20010128B1 (en) Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
ATE255911T1 (de) Verfahren zur herstellung von mikrokapseln
ES524518A0 (es) Un procedimiento para preparar un agente anti-inflamatorio
CY1108132T1 (el) Μεθοδος και εγκατασταση δια τη διαβροχη και επιστρωση χαρτιου
CA2130324A1 (en) Method and means for uniformly coating particulate material
FI906383A0 (fi) Pao retikulerade polyorganosiloxan baserade magnetiserbara core-shell-mikrobollar, foerfarande foer framstaellning av dessa och anvaendning av desamma i biologi.
CA2146964A1 (en) Particles having gelatin-aminodextran coatings of and processes for making same
EP0819742A3 (en) Permanent antistatic coating and coated polymeric film
DE69116358D1 (de) Träger zur gesteuerten wirkstoffabgabe
ATE273140T1 (de) Aufzeichnungsmaterial, herstellungsverfahren desgleichen und bebilderungsverfahren
FI906382A (fi) Pao polysilseskvioxan baserade magnetiserbara mikrobollar, foerfarande foer framstaellning av dessa och anvaendning av desamma i biologi.
CA2234615A1 (en) Sustained release particles
CA2105793A1 (en) Process for producing compositions for ruminants
JPH03250063A (ja) 芳香性塗料
NO303510B1 (no) Anordning for separasjon av substridsdeler
RU97115747A (ru) Способ получения микрокапсул с органическим фотохромным соединением для введения их в печатную краску
JPS5499373A (en) Method of formation of fluorescent substance layer for bulb
IT1232846B (it) Procedimento per la polverizzazione di gelatina, pittura, soluzione diresina contenente tale gelatina, strato di rivestimento film e tessutofinito
IT1273710B (it) Metodo per il rivestimento di particelle quali microcapsule microcomprese e simili ed apparecchiature per l'attuazione di esso

Legal Events

Date Code Title Description
NUG Patent has lapsed